openPR Logo
Press release

Spinal Muscular Atrophy Carrier Numbers On The Rise, Treatment Developments To Be Expedited

06-28-2017 02:59 PM CET | Health & Medicine

Press release from: Transparency Market Research

Spinal Muscular Atrophy Carrier Numbers On The Rise, Treatment

According to a new research report released by Transparency Market Research, barring a few drugs, the pipeline for spinal muscular atrophy (SMA) drugs is running dry currently. The few drugs that are present, however, are highly advanced medical technologies progressing through different phases of clinical trials. The key drugs in the spinal muscular atrophy pipeline are RG3039, scAAV9.CB.SMN, CK-2127107, RO6885247, LMI070, Olesoxime (TRO19622), and ISIS-SMNRx.

Ionis Pharma Solution Could Vastly Improve SMA Treatment

ISIS-SMNRx is a drug being developed by Ionis Pharmaceuticals for the treatment of spinal muscular atrophy. As of 2015, it was the only drug that had reached phase 3 of clinical trials. The studies are expected to be completed by July 2017.

Obtain Report Details @ http://www.transparencymarketresearch.com/spinal-muscular-atrophy-market.html

“Should this drug be approved for the treatment of spinal muscular atrophy, it will create a highly lucrative opportunity for both Ionis Pharma and Biogen Idec,” states a TMR analyst. “This drug is expected to be released in 2018 and hold high expectations from the healthcare industry for the treatment of spinal muscular atrophy.”

Growing SMA Carrier Frequency Speeds up Solutions R&D

One of the key drivers affecting the growth of the market for spinal muscular atrophy drugs is the increasing number of carriers of the defective SMA gene. As per the findings revealed by CureSMA, nearly one out of 50 people are carrying the SMA defect. Additionally, this statistic does not include a majority of the global population that for various reasons could not be included in the study. The total percentage of SMA gene carriers could therefore be effectively higher than previously mentioned.

This is creating a greater urge for healthcare and pharmaceutical organizations to create feasible solutions to treat spinal muscular atrophy, and is also pushing the organizations to increase awareness rates of SMA among people.

Lack of Advanced Research Slows Overall Development of SMA Treatments

There are currently multiple research institutes and government agencies that are working together to keep the total number of SMA cases in check. They do not, however, distinguish between the various types of spinal muscular atrophy afflicting the patients. This reduces the accuracy of patient diagnosis and eventually reduces the overall rate of development of treatments for spinal muscular atrophy. At the same time, it makes disease mapping for trends extremely difficult.

The resultant lack of research is therefore hindering the chances of innovative treatment solutions and the identification of disease progression.

Fill The Form To Gain Deeper Insights On This Market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7187

Large Areas Still Untapped for SMA Treatment to Provide Key Opportunities

The U.S. and Europe have designated SMA as an orphan disease. Between the U.S., Europe and Japan, between 25,000 and 50,000 people were diagnosed with spinal muscular atrophy as of June 2015, according to European Pharmaceutical Reviews. The total number of spinal muscular atrophy patients across the world is as yet unknown.

The absence of an approved drug-based treatment for spinal muscular atrophy combined with the unknown number of SMA patients leaves a major unrealized market for SMA drugs that can be tapped into for greater opportunities.

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Spinal Muscular Atrophy Carrier Numbers On The Rise, Treatment Developments To Be Expedited here

News-ID: 600374 • Views: 226

More Releases from Transparency Market Research

Wearable EEG Devices Market: Growing incidences of Neurovascular Disorders is Dr …
According to new market research titled 'Wearable EEG Devices Market to 2027 - Global Analysis and Forecasts by Channel and Application.' The global wearable EEG devices market is expected to reach US$ 1,556.35 Mn in 2027 from US$ 745.05 Mn in 2018. The market is projected to grow with a CAGR of 8.7% from 2019-2027. The report provides trends prevailing in the global wearable EEG devices market and the factors
Decentralized Electricity Generation Market - Global Industry Analysis, Share, G …
Global Decentralized Electricity Generation Market: Overview With the increasing installation of smart grids and the rising number of electricity generation resources, the power generation industry has been undergoing a significant change over the recent past. The modification in the grid structure, which permits decentralization of electricity generation, is acting as the main driving force behind the substantial growth of the global market for decentralized electricity generation. The main objective of this research
Global Sucralose Market Outlook In The Developed And Emerging Industry
Sucralose Market Overview Sugar substitute market is witnessing an increasing demand driven by the increasing sales of various sugar substitutes such as natural sweeteners and artificial sweeteners. Sucralose, an artificial sweetener used as a sugar substitute is highly preferred by consumers owing to its zero calorie attribute. Though sucralose is 600 times sweeter than sugar but interestingly it is not identified as the carbohydrate by the human body. Sucralose has its
Flavored Syrup Market - Growth Powered with Latest Development Scenario & Influe …
Flavored Syrup Market Introduction Global syrup market is witnessing a significant demand generated by the food and beverage industry. Consumers' increasing preference for different and personalized flavors in food has driven the syrup manufacturers to produce a wide range of flavored syrups. Flavored syrups contain artificial or natural flavorings mixed along with sugar and water. Obtain Report Details @ https://www.transparencymarketresearch.com/flavored-syrup-market.html Increasing demand of flavored syrups especially among the consumers contributes to the

All 5 Releases


More Releases for SMA

Spinal Muscular Atrophy Market | SMA Treatment Market | PBIGP
Spinal Muscular Atrophy Management Market is Expected to Increase Around US$ XX Mn by 2025, Due to Inherited Diseases that Affects the Functioning of Muscles Because of Deterioration. Analyst Speak: “The Spinal Muscular Atrophy Management Market is anticipated to reach about US$ XX Mn by 2024, and anticipated to expand at a CAGR over seven years of forecast period 2019-2025” due to increased inherited diseases that affects the normal functioning of
Global Hybrid Power Systems Market 2018 - Siemens, Emerson, Heliocentris, SMA
Accord Market, recently published a detailed market research study focused on the “Hybrid Power Systems Market” across the global, regional and country level. The report provides 360° analysis of “Hybrid Power Systems Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Hybrid Power
Sunny Sky Solar Is Providing SMA Inverters for Solar Panels
Sunny Sky Solar provides the best solar products from manufacturers of repute and whose products are independently tested and are proven to be trustworthy. The Brisbane based company has succeeded in an industry with fierce competition because they sell quality solar products that are robust and sell at reasonable prices. The Company has a team of qualified experts who work to install the solar products professionally for the client. All
Global Solar Microinverter Market 2018 - SMA, Sungrow, SunPower, Samil Power
The statistical surveying information incorporated into the Solar Microinverter report is the aftereffect of significant essential and optional research exercises. The report fragments the global market for Solar Microinverter based on makers, item compose, applications, and districts. In this report, each fragment is contemplated completely and measurements are introduced in detail. The report offers an exact outline of the global Solar Microinverter advertise covering key factors, for example, drivers and
Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2017, provides an overview of the Spinal Muscular Atrophy (SMA) (Central Nervous System) pipeline landscape. Spinal muscular atrophy (SMA) is a genetic disease that attacks nerve
Antidepressant Drugs Market- GSK, Pfizer, Lundbeck, Teva Pharmaceutical, SMA
Global Antidepressant Drugs Market Size, Status and Forecast 2022 provides Market information about Manufacturers, Countries, Type and Application.This Industry report also states Company Profile, sales, Antidepressant Drugs Market revenue and price, market share, market growth and gross margin by regions. Top Manufacturers/Key Players:- GSK Pfizer Lundbeck Teva Pharmaceutical SMA Eli Lilly and Company Forest Laboratories Schering-Plough Novartis Sanofi Enquiry for buying report @ https://goo.gl/szzxan The Global Antidepressant Drugs report gives a thorough situation of the present and gauge Antidepressant Drugs showcase procedures,